Sanofi Puts Faith In Rare Review Procedure For ‘Breakthrough’ Sleeping Sickness Drug

 
• By Neena Brizmohun

Sanofi believes its fully oral sleeping sickness treatment, fexinidazole, will support efforts to eliminate the disease by 2020. The European Medicines Agency is set to start reviewing the product soon with a view to it being used in Africa.

Tsetse fly
Sanofi believes fexinidazole could help eliminate sleeping sickness

More from Product Reviews

More from Pink Sheet